Clinical Trial Update: A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED) [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluating MK0431 in patients with hepatic insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure

Drugs mentioned

• MK0431

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Liver Insufficiency | Phase 1 | Status: COMPLETED